The prevalence of metabolic syndrome in cardiovascular patients in Iran: a systematic review and meta-analysis

[1] Dastoorpoor M(2019)Air pollution and hospital admissions for cardiovascular diseases in Ahvaz, Iran Sci Total Environ 652 1318-30

[2] Sekhavatpour Z(2019)Effect of O 3, PM 10 and PM 2.5 on cardiovascular and respiratory diseases in cities of France, Iran and Italy Environ Sci Pollut Res Int 26 32645-65

[3] Masoumi K(2012)Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review Revista Panamericana de Salud Pública. 32 131-9

[4] Mohammadi MJ(2017)Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome Global stroke statistics 12 13-32

[5] Aghababaeian H(2017)Association with Components of the Metabolic Syndrome in a Mediterranean Population at High Cardiovascular Risk J Health Popul Nutr 36 36-8

[6] Khanjani N(2019)Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study Nutrients 11 1493-32

[7] Hashemzadeh B(2016)Is metabolic syndrome a prognostic marker in patients at high cardiovascular risk? A long-term cohort study Indian J Dermatol Venereol Leprol 82 510-91

[8] Vahedian M(2019)The metabolic syndrome, depression, and cardiovascular disease: interrelated conditions that share pathophysiologic mechanisms Rev Port Cardiol 38 325-92

[9] Sicard P(2006)Quality of cholesterol screening and management with respect to the National Cholesterol Education’s Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina Medical Clinics 90 573-7

[10] Omidi Khaniabadi Y(2006)Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography Am Heart J 152 785-62

[1] Dastoorpoor M(2019)Air pollution and hospital admissions for cardiovascular diseases in Ahvaz, Iran Sci Total Environ 652 1318-30

[2] Sekhavatpour Z(2019)Effect of O 3, PM 10 and PM 2.5 on cardiovascular and respiratory diseases in cities of France, Iran and Italy Environ Sci Pollut Res Int 26 32645-65

[3] Masoumi K(2012)Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review Revista Panamericana de Salud Pública. 32 131-9

[4] Mohammadi MJ(2017)Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome Global stroke statistics 12 13-32

[5] Aghababaeian H(2017)Association with Components of the Metabolic Syndrome in a Mediterranean Population at High Cardiovascular Risk J Health Popul Nutr 36 36-8

[6] Khanjani N(2019)Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study Nutrients 11 1493-32

[7] Hashemzadeh B(2016)Is metabolic syndrome a prognostic marker in patients at high cardiovascular risk? A long-term cohort study Indian J Dermatol Venereol Leprol 82 510-91

[8] Vahedian M(2019)The metabolic syndrome, depression, and cardiovascular disease: interrelated conditions that share pathophysiologic mechanisms Rev Port Cardiol 38 325-92

[9] Sicard P(2006)Quality of cholesterol screening and management with respect to the National Cholesterol Education’s Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina Medical Clinics 90 573-7

[10] Omidi Khaniabadi Y(2006)Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography Am Heart J 152 785-62